P. Van Remoortere

2.1k total citations
74 papers, 1.6k citations indexed

About

P. Van Remoortere is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, P. Van Remoortere has authored 74 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 15 papers in Hepatology and 11 papers in Infectious Diseases. Recurrent topics in P. Van Remoortere's work include Hepatitis C virus research (15 papers), HIV/AIDS drug development and treatment (9 papers) and Liver Disease Diagnosis and Treatment (9 papers). P. Van Remoortere is often cited by papers focused on Hepatitis C virus research (15 papers), HIV/AIDS drug development and treatment (9 papers) and Liver Disease Diagnosis and Treatment (9 papers). P. Van Remoortere collaborates with scholars based in Belgium, United States and New Zealand. P. Van Remoortere's co-authors include P. Joos, J.P. Tollenaere, Marcus E. Brewster, Jef Peeters, Marianne Stowell Bracke, Gerben van ‘t Klooster, Piet Wigerinck, Laurent Schueller, Lieven Baert and Jan Rosier and has published in prestigious journals such as The Journal of Chemical Physics, Gastroenterology and Journal of Colloid and Interface Science.

In The Last Decade

P. Van Remoortere

71 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Van Remoortere Belgium 19 379 272 251 237 143 74 1.6k
Zhibin Zhu China 25 403 1.1× 36 0.1× 1.0k 4.0× 69 0.3× 117 0.8× 162 3.4k
Feng Qian China 34 271 0.7× 1.4k 5.3× 87 0.3× 228 1.0× 914 6.4× 98 4.2k
Anurag S. Rathore India 46 315 0.8× 215 0.8× 366 1.5× 37 0.2× 6.4k 44.4× 419 9.6k
Yin Zhang United States 23 196 0.5× 38 0.1× 51 0.2× 51 0.2× 526 3.7× 108 2.5k
Tomoki Yamashita Japan 22 77 0.2× 25 0.1× 131 0.5× 38 0.2× 177 1.2× 142 1.5k
Weimin Shi China 24 235 0.6× 54 0.2× 111 0.4× 4 0.0× 711 5.0× 142 1.9k
Robert L. Kruse United States 28 282 0.7× 5 0.0× 104 0.4× 114 0.5× 361 2.5× 104 2.2k
Jinghan Wang China 31 101 0.3× 14 0.1× 59 0.2× 20 0.1× 539 3.8× 193 3.0k
Pei Liu China 24 253 0.7× 97 0.4× 835 3.3× 111 0.5× 559 3.9× 149 3.1k

Countries citing papers authored by P. Van Remoortere

Since Specialization
Citations

This map shows the geographic impact of P. Van Remoortere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Van Remoortere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Van Remoortere more than expected).

Fields of papers citing papers by P. Van Remoortere

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Van Remoortere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Van Remoortere. The network helps show where P. Van Remoortere may publish in the future.

Co-authorship network of co-authors of P. Van Remoortere

This figure shows the co-authorship network connecting the top 25 collaborators of P. Van Remoortere. A scholar is included among the top collaborators of P. Van Remoortere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Van Remoortere. P. Van Remoortere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pierson, Wim, Marianne Tuefferd, Florence Herschke, et al.. (2023). A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults. Antiviral Therapy. 28(3). 211898638–211898638.
2.
Hu, Yue, Edward Gane, Leen Slaets, et al.. (2023). Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants. Antiviral Therapy. 28(1). 211877386–211877386. 2 indexed citations
3.
Lawitz, Eric, Fred Poordad, Julio Gutiérrez, et al.. (2020). Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT study. Health Science Reports. 3(2). e145–e145. 5 indexed citations
4.
Kakuda, Thomas N., Jeysen Yogaratnam, Christopher Westland, et al.. (2019). FRI-180-JNJ-64530440, a novel capsid assembly modulator: single- and multiple-ascending dose safety, tolerability and pharmacokinetics in healthy volunteers. Journal of Hepatology. 70(1). e469–e469. 7 indexed citations
5.
Bourgeois, Stefan, Yves Horsmans, Frederik Nevens, et al.. (2017). Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen. Antimicrobial Agents and Chemotherapy. 61(12). 6 indexed citations
6.
Bourgeois, Stefan, Hans Van Vlierberghe, Christophe Moreno, et al.. (2017). Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection. BMC Gastroenterology. 17(1). 26–26. 4 indexed citations
7.
Olszewska, Wieslawa, Gabriela Ispas, Corinna Schnoeller, et al.. (2010). Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model. European Respiratory Journal. 38(2). 401–408. 42 indexed citations
8.
Baert, Lieven, Gerben van ‘t Klooster, Koen Iterbeke, et al.. (2009). Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment. European Journal of Pharmaceutics and Biopharmaceutics. 72(3). 502–508. 185 indexed citations
9.
Reesink, H. W., Gregory Fanning, Christine J. Weegink, et al.. (2009). Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients. Gastroenterology. 138(3). 913–921. 123 indexed citations
10.
Gyseghem, Elke Van, Lieven Baert, Jan Rosier, et al.. (2008). Powder for reconstitution of the anti-HIV-1 drug TMC278 – Formulation development, stability and animal studies. European Journal of Pharmaceutics and Biopharmaceutics. 70(3). 853–860. 15 indexed citations
11.
Voets, Marieke, Jos Van Houdt, René Verloes, et al.. (2008). 855 ONCE-DAILY REGIMENS OF THE HCV NS3/4A-PROTEASE INHIBITOR TMC435350 ARE PREDICTED TO PROVIDE THERAPEUTIC EXPOSURE IN PLASMA AND LIVER. Journal of Hepatology. 48. S321–S321. 3 indexed citations
12.
Reesink, Hendrik W., René Verloes, Christine J. Weegink, et al.. (2008). 64 SAFETY OF THE HCV PROTEASE INHIBITOR TMC435350 IN HEALTHY VOLUNTEERS AND SAFETY AND ACTIVITY IN CHRONIC HEPATITIS C INFECTED INDIVIDUALS: A PHASE I STUDY. Journal of Hepatology. 48. S28–S29. 16 indexed citations
13.
Baert, Lieven, Laurent Schueller, Y. Tardy, et al.. (2008). Development of an implantable infusion pump for sustained anti-HIV drug administration. International Journal of Pharmaceutics. 355(1-2). 38–44. 14 indexed citations
14.
Schueller, Laurent, Lieven Baert, Sophie Lachau‐Durand, et al.. (2007). Dog model with implanted pump to test boosters for antiretroviral medication. International Journal of Pharmaceutics. 355(1-2). 45–52. 2 indexed citations
15.
Peeters, Jef, et al.. (2002). Characterization of the interaction of 2‐hydroxypropyl‐β‐cyclodextrin with itraconazole at pH 2, 4, and 7. Journal of Pharmaceutical Sciences. 91(6). 1414–1422. 241 indexed citations
16.
Remoortere, P. Van. (1979). Flow analysis of computer programs. Mathematics and Computers in Simulation. 21(4). 387–388. 16 indexed citations
17.
Remoortere, P. Van. (1979). Linear programming and network flows. Mathematics and Computers in Simulation. 21(4). 386–386. 56 indexed citations
18.
Remoortere, P. Van. (1979). Content addressable parallel processors.. Mathematics and Computers in Simulation. 21(4). 385–385. 1 indexed citations
19.
Remoortere, P. Van. (1979). Principles of continuous system simulation. — analog, digital and hybrid simulation in a computer science perspective.. Mathematics and Computers in Simulation. 21(3). 304–304.
20.
Remoortere, P. Van. (1979). Methodes et techniques de traitement du signal et applications aux mesures physiques. Mathematics and Computers in Simulation. 21(4). 388–388. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhibin Zhu Breakdown of academic impact, for papers by Feng Qian Breakdown of academic impact, for papers by Anurag S. Rathore Breakdown of academic impact, for papers by Yin Zhang Breakdown of academic impact, for papers by Tomoki Yamashita Breakdown of academic impact, for papers by Weimin Shi Breakdown of academic impact, for papers by Robert L. Kruse Breakdown of academic impact, for papers by Jinghan Wang Breakdown of academic impact, for papers by Pei Liu
Rankless by CCL
2026